Jennison Associates’s Neurogene NGNE Stock Holding History

Jennison Associates’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.3M	Sell	518,582 -9,103	-2%	-$251K	0.01%	352
2026 Q1	$10.6M	Sell	527,685 -5,403	-1%	-$105K	0.01%	378
2025 Q4	$11M	Buy	533,088 +138,999	+35%	+$3.46M	0.01%	387
2025 Q3	$6.83M	Buy	394,089 +226,526	+135%	+$4.55M	﹤0.01%	391
2025 Q2	$2.51M	Buy	167,563 +59,479	+55%	+$933K	﹤0.01%	428
2025 Q1	$1.27M	Buy	108,084 +35,488	+49%	+$616K	﹤0.01%	459
2024 Q4	$1.66M	Sell	72,596 -6,054	-8%	-$225K	﹤0.01%	457
2024 Q3	$3.3M	Buy	+78,650	New	+$3.05M	﹤0.01%	422
2014 Q2	–	Sell	-3,750	Closed	-$955K	–	744
2014 Q1	$955K	Buy	+3,750	New	+$964K	﹤0.01%	647

Other funds holding NGNE

RBI

Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Jennison Associates's NGNE Position: Q2 2026 in Review

Jennison Associates reduced its Neurogene (NGNE) stake by 1.7% in Q2 2026, selling an estimated $251K and leaving 518,582 shares worth $16.3M. The position accounts for 0.01% of the portfolio, ranked #352.

Jennison Associates first reported a position in NGNE in Q1 2014 and has held it in 9 quarters since. 22 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

Jennison Associates held 518,582 shares of Neurogene worth $16.3M as of Q2 2026.
Jennison Associates sold 9,103 Neurogene shares in Q2 2026, an estimated $251K.
Neurogene made up 0.01% of Jennison Associates's portfolio in Q2 2026, its #352 holding.
Jennison Associates first reported a position in Neurogene in Q1 2014 and has held it in 9 quarters since.
22 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.